AMP 2023| November 14-18, 2023 | Salt Palace Convention Center | Salt Lake City, Utah
Visit Asuragen, a Bio-Techne brand at Booth #1311 and join us at these sessions to learn how our products & services can empower you to provide better answers.
Corporate Workshops
Simple, Sensitive, and Scalable: QuantideX® Suite of Assays for Targeted MRD Monitoring of Leukemic Fusions
For highly sensitive detection of leukemic fusions using widely available qPCR equipment, Asuragen’s QuantideX qPCR BCR-ABL* kits offer IVD or RUO testing capabilities for molecular laboratories of any size. Learn about key features of these assays and see real-world performance data.
Speaker:
Holli M. Drendel, PhD, FACMGG
Director, Molecular Pathology
Laboratory Carolinas Pathology Group
November 15, 11:00 am, Room 251F
AmplideX® to the Rescue: One easy-to-implement test workflow enabling repeat expansion resolution, copy number assessment, and highly multiplexed variant detection.
Asuragen’s simple and scalable AmplideX technology, the gold standard for FMR1 analysis, has been expanded to cover other repeat disorder genes, copy number assays, and highly multiplexed variant detection. This workshop will report the experience of a clinical lab that adopted the AmplideX SMN1/2 Plus Kit* for detection of SMN1 and SMN2 copy numbers and genetic variants.
Speaker:
Sarah S. Murray, PhD, FACMG
Clinical Professor, Department of Pathology
Director, Medical Genetics and Genomics University of California San Diego
November 15, 12:00 pm, Room 251F
*For Research use only.
Posters
Visit our posters to view new data reinforcing our commitment to more equitable healthcare, comprehensive genetic coverage, and novel approaches to cancer monitoring & management.
Impact of Variants of Varying Clinical Consequence in Underrepresented Populations and Implications for a Minimum Variant Set for Pan-Ancestry Cystic Fibrosis Carrier Screening
Presenter:
Brian Haynes, PhD, CSO, Asuragen & Head of Bioinformatics, Molecular Diagnostics Division
G016, Genetics
Friday, November 17th, 9:15am -10:15am.
Accurate Genotyping of Complex, Clinically-Relevant Variants in 11 Hard-to-Decipher Genes by Combining Novel PCR Chemistries with Any-Length Nanopore Sequencing for Carrier Screening
Presenter:
Brennan Greenlee, MS, Sr. Research Associate, Asuragen
G030, Genetics
Friday, November 17th, 9:15am -10:15am.
Development of a Novel Exosome-based, Multiplexed RT-qPCR Technology for Rapid and Accurate Detection of Circulating Tumor Acquired Resistance Variants in ESR1 at ≤ 0.1% Frequency
Presenter:
Julie Thibert, MS, Scientist, Asuragen
ST078, Solid Tumors
Friday, November 17th, 9:15am -10:15am.
Prototype RT-qPCR PML:RARA Reagents and a Commercial PML-RARA Kit Yield Highly Correlated Results
Presenter:
Ila Wolf, PhD, Scientist, Asuragen
H063, Hematopathology
Saturday, November 18th, 9:15am -10:15am
RSVP for Asuragen's Customer Reception
Award Spotlight
Bio-Techne is proud to share that Dr. Jordan Laser received the AMP Meritorious Service Award this year to recognize his work behind the scenes to position AMP as the premier molecular diagnostics professional association around the world.
Dr. Laser serves as Senior Director, Clinical and Medical Affairs, for Bio-Techne's Diagnostics and Genomics Segment.